ArticleFrontiers in cardiovascular medicine2024

Ten-year clinical outcomes of everolimus- and biolimus-eluting coronary stents vs. everolimus-eluting bioresorbable vascular scaffolds-insights from the EVERBIO-2 trial.

Samir Bengueddache et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.